Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Impact of sleep disorder treatment on fatigue in multiple sclerosis.
Soluble thrombomodulin levels in plasma of multiple sclerosis patients and their implication.
The Vitamin D to Ameliorate Multiple Sclerosis (VIDAMS) trial: study design for a multicenter, randomized, double-blind controlled trial of vitamin D in multiple sclerosis.
Analysis of Onset Mechanisms of a Sphingosine 1-Phosphate Receptor Modulator Fingolomod-Induced Atrioventricular Conduction Block and QT-Interval Prolongation.
Value and Efficacy of Transcranial Direct Current Stimulation in the Cognitive Rehabilitation: A Critical Review Since 2000.
NQO1-dependent redox cycling of idebenone: effects on cellular redox potential and energy levels.
Effects of prophylactic and therapeutic teriflunomide in transcranial magnetic stimulation-induced motor-evoked potentials in the Dark Agouti rat model of experimental autoimmune encephalomyelitis.
ExtaviJect® 30G device for subcutaneous self-injection of interferon beta-1b for multiple sclerosis: a prospective European study.
Complexity of trophic factor signaling in experimental autoimmune encephalomyelitis: Differential expression of neurotrophic and gliotrophic factors.
Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial.
TGN1412: From Discovery to Disaster.
The epidemiology of multiple sclerosis in three Australian cities: Perth, Newcastle and Hobart.
[Results of a comparative clinical trial of the Russian Β - interferon-1b bioanalogue (infibeta)].
Roche's MabThera approved for two vasculitis indications in UK
Tumefactive Multiple Sclerosis presenting as Acute Ischemic Stroke.
Leflunomide inhibits pyrimidine de novo synthesis in mitogen-stimulated T-lymphocytes from healthy humans.
Review of the novelties presented at the 27th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II).
Genzyme’s Lemtrada Recommended for Reimbursement on NHS by the National Institute for Health and Care Excellence (NICE)
TGFβ Signaling Regulates the Timing of CNS Myelination by Modulating Oligodendrocyte Progenitor Cell Cycle Exit through SMAD3/4/FoxO1/Sp1.
RILUTEK®
Imovane: Best Online Pharmacy
Investigation of the mechanism of action of alemtuzumab in a human CD52 transgenic mouse model.
Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon Beta 1a dosages for multiple sclerosis.
The topograpy of demyelination and neurodegeneration in the multiple sclerosis brain.
Bench to bedside: tempering antigen-presenting cells in multiple sclerosis.

Pages